Clinical Trial Update: A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD) [Phase 3]

View source ↗

Summary

This clinical trial entry describes a long-term extension study of vedolizumab in children and teenagers with ulcerative colitis or Crohn's disease, in Phase 3 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Vedolizumab (vedolizumab)

Snippet

Sponsor: Takeda | Conditions: Ulcerative Colitis, Crohn's Disease | Phase 3 | Status: RECRUITING